← FDA DRUG APPROVALS

FDA NDA · NDA013093

SULFABID

Sponsor: PHARM RES ASSOC

APPLICATION
NDA013093
TYPE
NDA
LATEST ACTION
1977-10-07
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

SULFABIDDiscontinued
SULFAPHENAZOLE 500MG/5ML · SUSPENSION · ORAL

Approval history

1977-10-07Manufacturing (CMC) · Supplement 1 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →